Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Dysplasia 1Papillomavirus Infections 1

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 4human papillomavirus vaccine, L1 type 16, 18 3Papillomavirus Vaccines 3Imiquimod 3Colposcopy 3Blood Specimen Collection 3Vaccines 2VGX-3100 2Indomethacin 2Cyclophosphamide 2Conization 2fludarabine phosphate 1fludarabine 1aldesleukin 1X-Rays 1Vaccines, Synthetic 1Vaccines, DNA 1Spectrometry, Fluorescence 1Respiratory Function Tests 1Proflavine 1Prochlorperazine 1Positron-Emission Tomography 1Polymerase Chain Reaction 1Pemetrexed 1Papanicolaou Test 1Ondansetron 1Omeprazole 1O(6)-codeine methyl ether 1Methods 1Meperidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Uterine Cervical Dysplasia × AKAP13 protein, human × Clear all
NCT00929526 2016-10-20

Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study

GlaxoSmithKline

Phase 3 Completed
752 enrolled 21 charts
Gynecologic

Uterine Cervical Dysplasia, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡